From the Wires
Abattis Signs Georges Laraque Management Inc. as Media and Product Champion
By: Marketwired .
Jan. 7, 2013 09:46 AM
VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 01/07/13 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CNSX:FLU)(PINKSHEETS:ATTBF) announces the engagement of Georges Laraque Management Inc. effective January 1, 2013. Georges Laraque Management Inc. will be assisting the Company in Marketing and Branding all of the Natural Health Products designed by Abattis . As partial consideration for Georges Laraque Management Inc. entering into this agreement and providing services thereunder, the Company agreed to issue 150,000 shares of the Company at a deemed price of $0.10/share. The shares will be subject to a 4 month hold period as required by applicable securities laws.
Mr. Mike Withrow, Chief Executive Officer on behalf of the Company, stated, "We are pleased to have Mr. Laraque join our Abattis team. His professionalism and dedication to his political beliefs as Deputy Leader of the Green Party of Canada and his work done in Haiti, and PETA spokesperson, along with being Vegan, he has demonstrated during his career not only does have the ability but passion and drive and will help Abattis and its brands to be recognized and respected in political arenas, Athletic Performance Markets, Vegan Nutrition, and Animal Wellness Markets."
Mr. Georges Laraque, Retired NHL Star and current Deputy Leader of the Green Party of Canada and Spokes Person for PETA stated, "I am very excited about this opportunity to work with such a great company and be able to further my support in the Natural Health Products arena, I see Abattis as a well poised company with advanced Pharmaceutical Grade Vertical Farming, Packaging and Extraction technologies to ensure people safety with the purest compounds with complete traceability from A-Z and I look forward to helping this company grow."
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients and bio-similar compounds for use in Pharmaceuticals, Nutraceutical, Cosmetic and Animal Nutrition markets. The company also has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Company's website at www.abattis.com.
ON BEHALF OF THE BOARD
Michael Withrow, President & CEO
Neither the CNSX Exchange nor its regulations services accepts responsibility for the adequacy or accuracy of this release.
SOA World Latest Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week